IBD
Comprehensive learning program
IBD Comprehensive Learning Program is an extensive educational activity aimed at increasing awareness about and addressing the pressing problems that are faced in the domain of gastroenterology as a whole. With learning being disseminated through digital platform, and print sources, the program also entails live interaction with expert faculty from Colitis & Crohn’s Foundation (India).
Colitis & Crohn’s Foundation (India) has been established as a national, not-for-profit, voluntary academic society by a team of people with special interest in inflammatory bowel disease. Its composition is multi - disciplinary ; comprising of physicians, surgeons & other professionals dedicated to assuring high quality patients care by advancing and promoting the science & practice of management of patients with Inflammatory Bowel Disease.
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history in Japan.
Topics in Focus
Epidemiology, Pathogenesis, Diagnosis and Differential Diagnosis of IBD
The global incidence and prevalence of inflammatory bowel disease (IBD) are rising. Environmental factors, genetic factors, gut microbiota, and host immune response are responsible for the pathogenesi...
Management of Ulcerative Colitis
The therapeutic landscape for inflammatory bowel disease (IBD) is rapidly evolving. The use of glucocorticoids, immunosuppressive and biological agents can severely inhibit individual patient’s immuni...
Archive of Webinar on Management Issues in Ulcerative Colitis
Live webinar on 16th January, from 12 pm to 1.30 pm Ulcerative colitis (UC) is a chronic and/or relapsing inflammation of the colonic mucosa. The medical treatment induces and maintains clinical remi...
Management of Crohn’s Disease
One-third of CD patients manifest with fistulizing disease, which is one of the most challenging issues. The perianal or non-perianal fistulizing disease deteriorates the patient’s quality of life and...
Special considerations and Recent Developments in IBD management
Inflammatory bowel disease (IBD) is an independent risk factor for colorectal cancer (CRC) as a result of low and high-grade dysplasia. With recent advances in understanding the nature of IBD, there...
Archive of Webinar on Case Based Discussions in Crohn's Disease
IBD requires tailored and personalized approach in special situation or conditions particularly in pediatrics, elderly population and during vaccination.